Store
2026 Oncology in Diagnostic Imaging Market Outlook Report
Publication Date: August 19, 2026
Tags: Computerized Tomography (CT), Magnetic Resonance Imaging (MRI), Mammography, Nuclear Medicine, Oncology and Cancer, PET/CT, Ultrasound, X-ray
Pages: 158
SKU: 26-067
IMV’s 2026 Oncology in Diagnostic Imaging Market Outlook Report gives medical imaging manufacturers, suppliers, and strategy teams a current, quantified view of how U.S. hospitals and outpatient imaging centers perform oncology-related imaging across CT, MRI, PET, SPECT, C-arm, mammography, X-ray, and ultrasound systems.
The report is built on an IMV-hosted online survey of 215 qualified radiology administrators and managers, technologists, and radiologists who are involved in operating those departments and in equipment purchase decisions. It reports department priorities, procedure volume and mix, the installed base of scanners, equipment purchase plans through 2029, industry trends including AI adoption, and site operations characteristics, with 2026 results compared to 2023 to show where the market is heading.
The report includes more than 150 slides with over 100 graphs and exhibits in PowerPoint format, and it will allow you to:
- Prioritize facility types with higher purchase intent and known budgets and defend share against competitive displacement.
- Size demand by modality and segment and focus commercial effort where oncology-related imaging volume is concentrated.
- Align product roadmaps and R&D to the priorities and AI use cases that sites report they are adopting.
- Benchmark installed base market share by manufacturer, and track how it has shifted since 2023.
Findings can be viewed at the total-market level and hospital bed size, so teams can move from a top-level read to the specific segments that shape their plans.
What You’ll Learn
Oncology-related department priorities and outlook
- What are the top priorities for imaging departments that perform oncology-related scans?
- How have department priorities shifted since 2023, and what is rising fastest?
Oncology-related imaging procedure volumes
- How many oncology-related imaging procedures are performed per site by modality?
- What is the mix of diagnostic versus screening procedures and of inpatient versus outpatient settings?
Installed base and purchase plans
- What is the installed base market share by manufacturer across modalities?
- What is the average age of imaging systems at the point of replacement?
- What are the purchase plans for CT, MRI, PET, SPECT, mammography, X-ray, ultrasound, and C-arm systems over the next three years?
- How do plans differ between first-time placements and replacements?
Trends
- How are sites using AI tools in oncology-related imaging?
- What operational shifts are reshaping departments?
Demographics and site operations
- What are typical wait times for scheduled oncology-related imaging appointments?
- How are patients scheduled across imaging and central scheduling departments?
- How do findings vary by site type?
Methodology and Sample
This report utilizes the results from an IMV-hosted online survey fielded from April 27 to June 9, 2026 with 215 radiology administrators and managers, technologists, and radiologists from a sample of hospitals and imaging centers performing oncology-related imaging services across the United States. Respondents were involved in the operation or management of imaging for oncology patients and in the purchase decision process.
Study Objectives
- Determine priorities for departments performing oncology-related imaging across modalities in hospitals and outpatient imaging centers.
- Identify trends in oncology-related imaging procedure volume and mix across modalities.
- Describe the installed base of scanners used for oncology-related imaging.
- Describe purchase plans for oncology-related imaging equipment.
- Identify oncology-related imaging trends in hospitals and outpatient imaging centers.
- Describe demographics and site operations characteristics for departments that perform oncology-related imaging.
Manufacturers Covered
Bayer, Bracco, Canon, Carestream, Fujifilm, GEHC, Guerbet, Hologic, Philips, Shimadzu, Siemens
What’s Included
- A digital PowerPoint report of more than 150 slides with over 100 graphs and exhibits.
- A complimentary recording of an executive summary presentation with every purchase.
- 2026 results trended against 2023 across priorities, installed base, and purchase plans.
How to Order
To order, or for licensing and bulk pricing, contact IMV at 703-778-3080, ext. 1033, or sales@imvinfo.com.
| # | Chart Title | Page |
|---|---|---|
| 1 | Priorities to the Mission of Imaging Departments, with Regard to Oncology-Related Imaging, as of 2026 Survey | 14 |
| 2 | Hospitals vs. Non-Hospitals: Priorities to the Mission of Imaging Departments, with Regard to Oncology-Related Imaging, as of 2026 Survey | 15 |
| 3 | Priorities to the Mission of Imaging Departments, with Regard to Oncology-Related Imaging, by Hospital Bed Size, as of 2026 Survey | 16 |
| 4 | Ranking of Priorities to the Mission of Imaging Departments, with Regard to Oncology-Related Imaging, by Hospital Bed Size, as of 2023 to 2026 Survey | 17 |
| 5 | 2026 Department Outlook for Oncology-Related Imaging Procedure Volume, Reimbursement Levels, Revenue, and Net Income, Compared to 2025 | 18 |
| 6 | 2026 Imaging Department Outlook for Oncology-Related Patients, Procedures, Reimbursement per Patient, Revenue, and Net Income/Profits, by Site Type, Compared to 2025 | 19 |
| 7 | Distribution of Requested Capabilities & Services by Category % of Total Responses (n=190) | 20 |
| 8 | Imaging Equipment Used for Oncology-Related Imaging Procedures, as of 2026 Survey | 22 |
| 9 | Imaging Equipment Used for Oncology-Related Imaging Procedures, 2023 to 2026 | 23 |
| 10 | Imaging Equipment Used for Oncology-Related Imaging Procedures, by Hospital vs. Non-Hospital, as of 2026 Survey | 24 |
| 11 | Imaging Equipment Used for Oncology-Related Imaging Procedures, by Hospital Bed Size, as of 2026 Survey | 25 |
| 12 | Imaging Equipment Used for Oncology-Related Imaging Procedures, by Hospital Ownership Type, as of 2026 Survey | 26 |
| 13 | Distribution of Sites, by Number of Imaging Systems Used for Oncology-Related Imaging, by Modality, by Hospital Bed Size, as of 2026 Survey | 27 |
| 14 | Distribution of Sites, by Number of Imaging Systems Used for Oncology-Related Imaging, by Modality, by Hospital Bed Size, as of 2026 Survey | 28 |
| 15 | Average Units Per Site Used for Oncology-Related Imaging Procedures, by Equipment Type, by Site Type, as of 2026 Survey | 29 |
| 16 | Imaging Equipment Manufacturers Used for Oncology-Related Imaging, All Modalities, as of 2026 Survey | 30 |
| 17 | Imaging Equipment Manufacturers Used for Oncology-Related Imaging, All Modalities, 2023 to 2026 | 31 |
| 18 | Imaging Equipment Manufacturers Used for Oncology-Related Imaging, All Modalities, by Site Type, as of 2026 Survey | 32 |
| 19 | Imaging Equipment Manufacturers Used for Oncology-Related Imaging Procedures, by Modality, as of 2026 Survey | 33 |
| 20 | Contrast Media Power Injector Manufacturers Used for Oncology-Related Imaging Procedures, as of 2026 Survey | 34 |
| 21 | 2026 Oncology-Related Procedures per Site, by Modality, by Hospital vs. Non-Hospital | 36 |
| 22 | Whether 2026 Oncology-Related Procedures are Anticipated to Increase, Stay the Same, or Decrease Compared to 2025, by Modality, as of 2026 Survey | 37 |
| 23 | Average Oncology-Related Imaging Procedures per Site, 2024-2026, by Modality | 38 |
| 24 | Mix of Screening vs. Diagnostic Oncology Imaging Procedures, by Modality, 2026 | 39 |
| 25 | Mix of Screening vs. Diagnostic Oncology Imaging Procedures Using CT, by Site Type, 2026 | 40 |
| 26 | Mix of Screening vs. Diagnostic Oncology Imaging Procedures Using MRI, by Site Type, 2026 | 41 |
| 27 | Mix of Screening vs. Diagnostic Oncology Imaging Procedures Using PET, by Site Type, 2026 | 42 |
| 28 | Mix of Screening vs. Diagnostic Oncology Imaging Procedures Using SPECT, by Site Type, 2026 | 43 |
| 29 | Mix of Screening vs. Diagnostic Oncology Imaging Procedures Using C-Arm, by Site Type, 2026 | 44 |
| 30 | Mix of Screening vs. Diagnostic Oncology Imaging Procedures Using Mammography, by Site Type, 2026 | 45 |
| 31 | Mix of Screening vs. Diagnostic Oncology Imaging Procedures Using Ultrasound, by Site Type, 2026 | 46 |
| 32 | Mix of Screening vs. Diagnostic Oncology Imaging Procedures Using X-Ray, by Site Type, 2026 | 47 |
| 33 | Mix of Inpatient, Outpatient, and Emergency Oncology Imaging Procedures, by Modality, 2026 | 48 |
| 34 | Mix of Adult vs. Pediatric Oncology Imaging Procedures, by Modality, 2026 | 49 |
| 35 | Average Oncology-Related Procedures Using CT per Site, 2025 vs. 2026, by Site Type | 50 |
| 36 | Whether 2026 Oncology-Related Procedures Using CT are Anticipated to Increase, Stay the Same, or Decrease Compared to 2025, by Modality, as of 2026 Survey | 51 |
| 37 | Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using CT, by Hospital Bed Size, 2026 | 52 |
| 38 | Average Oncology-Related Procedures Using MRI per Site, 2025 vs. 2026, by Site Type | 53 |
| 39 | Whether 2026 Oncology-Related Procedures Using MRI are Anticipated to Increase, Stay the Same, or Decrease Compared to 2025, by Modality, as of 2026 Survey | 54 |
| 40 | Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using MRI, by Hospital Bed Size, 2026 | 55 |
| 41 | Average Oncology-Related Procedures Using PET per Site, 2025 vs. 2026, by Site Type | 56 |
| 42 | Whether 2026 Oncology-Related Procedures Using PET are Anticipated to Increase, Stay the Same, or Decrease Compared to 2025, by Modality, as of 2026 Survey | 57 |
| 43 | Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using PET, by Hospital Bed Size, 2026 | 58 |
| 44 | Average Oncology-Related Procedures Using SPECT per Site, 2025 vs. 2026, by Site Type | 59 |
| 45 | Whether 2026 Oncology-Related Procedures Using SPECT are Anticipated to Increase, Stay the Same, or Decrease Compared to 2025, by Modality, as of 2026 Survey | 60 |
| 46 | Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using SPECT, by Hospital Bed Size, 2026 | 61 |
| 47 | Average Oncology-Related Procedures Using C-Arm per Site, 2025 vs. 2026, by Site Type | 62 |
| 48 | Whether 2026 Oncology-Related Procedures Using C-Arm are Anticipated to Increase, Stay the Same, or Decrease Compared to 2025, by Modality, as of 2026 Survey | 63 |
| 49 | Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using C-Arm, by Hospital Bed Size, 2026 | 64 |
| 50 | Average Oncology-Related Procedures Using Mammography per Site, 2025 vs. 2026, by Site Type | 65 |
| 51 | Whether 2026 Oncology-Related Procedures Using Mammography are Anticipated to Increase, Stay the Same, or Decrease Compared to 2025, by Modality, as of 2026 Survey | 66 |
| 52 | Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using Mammography, by Hospital Bed Size, 2026 | 67 |
| 53 | Average Oncology-Related Procedures Using X-Ray per Site, 2025 vs. 2026, by Site Type | 68 |
| 54 | Whether 2026 Oncology-Related Procedures Using X-Ray are Anticipated to Increase, Stay the Same, or Decrease Compared to 2025, by Modality, as of 2026 Survey | 69 |
| 55 | Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using X-Ray, by Hospital Bed Size, 2026 | 70 |
| 56 | Average Oncology-Related Procedures Using Ultrasound per Site, 2025 vs. 2026, by Site Type | 71 |
| 57 | Whether 2026 Oncology-Related Procedures Using Ultrasound are Anticipated to Increase, Stay the Same, or Decrease Compared to 2025, by Modality, as of 2026 Survey | 72 |
| 58 | Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using Ultrasound, by Hospital Bed Size, 2026 | 73 |
| 59 | Contrast Usage in Oncology-Related CT and MRI Imaging Procedures, 2026 | 74 |
| 60 | Percent of Oncology Imaging Procedures Performed on Obese Patients, by Modality, 2026 | 75 |
| 61 | Primary Reasons for Anticipated Increase in Oncology-Related Imaging Procedures in 2026, by Modality, as of 2026 Survey | 76 |
| 62 | Imaging Modalities Most Frequently Used in Oncology-Related Imaging Exams, by Cancer Type, as of 2026 Survey | 77 |
| 63 | Imaging Modalities Most Frequently Used in Hospital Sites for in Oncology-Related Imaging Exams, by Cancer Type, as of 2026 Survey | 78 |
| 64 | Imaging Modalities Most Frequently Used in Non-Hospital Sites for in Oncology-Related Imaging Exams, by Cancer Type, as of 2026 Survey | 79 |
| 65 | Primary Sources of Referrals for Oncology-Related Imaging Exams, as of 2026 Survey | 80 |
| 66 | Ranking of Primary Sources of Referrals for Oncology-Related Imaging Exams, as of 2026 Survey | 81 |
| 67 | Top 3 Ranking for Sources Referring Patients for Oncology-Related Imaging, by Site Type, as of 2026 Survey | 82 |
| 68 | Distribution of Referral Scan Types by Category % of Total Responses (n=100) | 83 |
| 69 | Percent of Sites Planning to Purchase Imaging Equipment for Use in Oncology-Related Imaging Procedures, from 2026 through 2028, by Modality, by Hospital vs. Non-Hospital, as of 2026 Survey | 85 |
| 70 | Percent of Sites Planning to Purchase Imaging Equipment for Use in Oncology-Related Imaging Procedures, from 2026 through 2028, by Modality, by Hospital Bed Size, as of 2026 Survey | 86 |
| 71 | Distribution of Planning to Purchase Imaging Equipment for Use in Oncology-Related Imaging Procedures, by Number of Units Planned, by Modality, as of 2026 Survey | 87 |
| 72 | Budget Status for Planned Imaging Equipment Purchases, by Modality, as of 2026 Survey | 88 |
| 73 | Plans to Purchase New vs. Refurbished/Used Units, by Modality, as of 2026 Survey | 89 |
| 74 | Plans to Purchase New vs. Refurbished/Used Units, by Modality, as of 2026 Survey | 90 |
| 75 | Plans to Purchase Additional vs. Replacement Units, by Modality, as of 2026 Survey | 91 |
| 76 | Average Age of Oldest Unit Being Replaced, by Modality, as of 2026 Survey | 92 |
| 77 | Average Age of Oldest Unit Being Replaced, by Modality, 2023 to 2026 | 93 |
| 78 | Manufacturers Considered for Next Imaging Equipment Purchase, as of 2026 Survey | 94 |
| 79 | Distribution of 2026 Equipment Budgets to be used on Oncology-Related Imaging Equipment | 95 |
| 80 | Distribution of Oncology-Related Imaging Equipment Budgets, 2024 to 2028 | 96 |
| 81 | Distribution of 2026 Oncology-Related Imaging Equipment Budgets, by Site Type | 97 |
| 82 | Factors Affecting the Future Outlook for Oncology-Related Imaging at Your Facility, Over the Next Few Years, as of 2026 Survey | 99 |
| 83 | Hospitals vs. Non-Hospitals: Factors Affecting the Future Outlook for Oncology-Related Imaging at Your Facility Over the Next Few Years, as of 2026 Survey | 100 |
| 84 | Factors Affecting the Future Outlook for Oncology-Related Imaging at Your Facility Over the Next Few Years, by Hospital Bed Size, as of 2026 Survey | 101 |
| 85 | Ranking of Priorities to the Mission of Imaging Departments, with Regard to Oncology-Related Imaging, by Hospital Bed Size, as of 2023 to 2026 Survey | 102 |
| 86 | Current Use and Consideration of Artificial Intelligence, with Oncology-Related Imaging Procedures, as of 2026 Survey | 103 |
| 87 | Current Use and Consideration of Artificial Intelligence, with Oncology-Related Imaging Procedures, 2023 to 2026 | 104 |
| 88 | Current Use and Consideration of Artificial Intelligence, with Oncology-Related Imaging Procedures, by Site Type, as of 2026 Survey | 105 |
| 89 | Primary Reasons Oncology Patients are Referred to the Imaging Department, as of 2026 Survey | 106 |
| 90 | #1/#2 Ranking for Reasons Patients are Referred to the Imaging Department, by Site Type, as of 2026 Survey | 107 |
| 91 | Types of Physicians Receiving Oncology-Related Imaging Scans and Related Information, as of 2026 Survey | 108 |
| 92 | #1/#2 Ranked Types of Physicians Receiving Oncology-Related Imaging Scans and Related Information, by Site Type, as of 2026 Survey | 109 |
| 93 | Primary Methods of Sharing Oncology-Related Images and Patient Information with Physicians, as of 2026 Survey | 110 |
| 94 | #1/#2 Ranking for Primary Methods of Sharing Oncology-Related Images and Patient Information with Physicians, by Site Type, as of 2026 Survey | 111 |
| 95 | Whether Facility Participates in Tumor Conferences, overall and by Site Type, as of 2026 Survey | 112 |
| 96 | Whether Facility Participates in Tumor Conferences, 2023 to 2026 | 113 |
| 97 | Physician Specialties Represented in Tumor Conferences, as of 2026 Survey | 114 |
| 98 | Physician Specialties Represented in Tumor Conferences, by Site Type, as of 2026 Survey | 115 |
| 99 | Distribution of 2025 AI Impact by Category % of Total Responses (n=180) | 116 |
| 100 | Distribution of Expected 2026 AI Impact by Category % of Total Responses (n=199) | 117 |
| 101 | Hospital vs. Non-Hospital Mix of Sites Performing Oncology-Related Imaging, with Bed Size Mix of Hospital Locations, as of 2026 Survey | 119 |
| 102 | Location Type by Site Type; and Ownership of Non-Hospital Imaging Facilities, as of 2026 Survey | 120 |
| 103 | Academic/University Hospital Status; and Hospital Ownership Type, as a Percentage of Hospital Sites, by Bed Size, as of 2026 Survey | 121 |
| 104 | Whether Patients are Scheduled Within Imaging Department or by Central Scheduling Department, overall and by Site Type, as of 2026 Survey | 122 |
| 105 | Typical Waiting Time for Scheduled Imaging Appointment, by Modality, as of 2026 Survey | 123 |
| 106 | Typical Waiting Time for Scheduled Imaging Appointment, by Modality, 2023 to 2026 | 124 |
| 107 | Typical Waiting Time for Scheduled Imaging Appointment, by Modality, as of 2026 Survey | 125 |
| 108 | Methodology | 126 |
| 109 | About IMV | 158 |
Related products
2024 Cardiology in Diagnostic Imaging Market Outlook
August 1, 2024
IMV’s 2024 Cardiology in Diagnostic Imaging Market Outlook Report explores cardiology-related imaging market factors across CT, MRI, PET, SPECT, C-Arm, Mammography, X-Ray and Ultrasound systems. The report examines aspects of market trends, procedure volume, installed base, equipment purchase plans, contrast utilization/budgets, and site operations characteristics. Survey results are projected to the identified universe of cardiology-related…
Price range: $5,600.00 through $8,000.00
2023 Oncology in Diagnostic Imaging Market Outlook Report
August 6, 2025
IMV’s 2023 Oncology in Diagnostic Imaging Market Outlook Report explores oncology-related imaging market factors across CT, MRI, PET, SPECT, C-Arm, Mammography, X-Ray and Ultrasound systems. The report examines aspects of market trends, procedure volume, installed base, equipment purchase plans, contrast utilization/budgets, trends, and site operations characteristics. Survey results are projected to the identified universe of…
Price range: $5,600.00 through $8,000.00
2025 Neurology in Diagnostic Imaging Market Outlook
September 3, 2025
IMV’s 2025 Neurology in Diagnostic Imaging Market Outlook Report explores neurology-related imaging market factors across CT, MRI, PET, SPECT, C-Arm, X-Ray and Ultrasound systems. The report examines aspects of market trends, procedure volume, installed base, equipment purchase plans, contrast utilization/budgets, and site operations characteristics. Survey results are projected to the identified universe of neurology-related imaging…
Price range: $5,600.00 through $8,000.00
